tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
TVRD
Tvardi Therapeutics
RESEARCH TOOLSreports

Tvardi Therapeutics (TVRD) Stock News & Sentiment

Compare
2,526 Followers
Tvardi Therapeutics updates STAT3 fibrosis-focused clinical pipeline
Premium
Company Announcements
Tvardi Therapeutics updates STAT3 fibrosis-focused clinical pipeline
19d ago
8K
TVRD
Tvardi Therapeutics: Buy Rating Reaffirmed Amid Upcoming Catalysts and Risk-Reward Scenario
Premium
Ratings
Tvardi Therapeutics: Buy Rating Reaffirmed Amid Upcoming Catalysts and Risk-Reward Scenario
2M ago
TVRD
Tvardi Therapeutics Advances STAT3 Inhibitor Clinical Trials
Premium
Company Announcements
Tvardi Therapeutics Advances STAT3 Inhibitor Clinical Trials
3M ago
8K
TVRD
Tvardi Therapeutics Faces Financial Hurdles Amidst Ongoing Product Development Challenges
Premium
Company Announcements
Tvardi Therapeutics Faces Financial Hurdles Amidst Ongoing Product Development Challenges
3M ago
TVRD
Promising Pipeline and Financial Stability Drive Buy Rating for Tvardi Therapeutics
Premium
Ratings
Promising Pipeline and Financial Stability Drive Buy Rating for Tvardi Therapeutics
3M ago
TVRD
Tvardi Therapeutics’ Liver Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
Tvardi Therapeutics’ Liver Cancer Study: A Potential Game-Changer?
3M ago
TVRD
Tvardi Therapeutics Faces Setback in Phase 2 Trial
Premium
Company Announcements
Tvardi Therapeutics Faces Setback in Phase 2 Trial
4M ago
8K
TVRD
More TVRD News >

TVRD News on the Web

Tvardi Therapeutics upgraded to Buy from Neutral at Lucid Capital
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Capricor Therapeutics (CAPR), Tvardi Therapeutics (TVRD)
TipRanks News
Bullish
Tvardi Therapeutics updates STAT3 fibrosis-focused clinical pipeline
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Anika Therapeutics (ANIK)
TipRanks News
Bullish
Tvardi Therapeutics announces further Phase 2 REVERT IPF data
TipRanks News
Neutral
Tvardi Therapeutics Advances STAT3 Inhibitor Clinical Trials
TipRanks News
Neutral
Tvardi (TVRD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Zacks
Neutral
Tvardi Therapeutics Faces Financial Hurdles Amidst Ongoing Product Development Challenges
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
TVRD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average72%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TVRD’s Media Buzz Sentiment?
1 articles about TVRD were published this week. In an average week, 1 articles are published.
    What is TVRD’s weekly average amount of articles?
    In an average week, 1 articles about TVRD are published.
      What is TVRD’s News Sentiment?
      100% of articles about TVRD were positive this week, compared to its sector average of 72%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        QNCXQuince Therapeutics
        RMDResmed
        PLXProtalix
        INNVInnovAge Holding
        Showing the stocks with the most bullish news sentiment over the past week